Zheng Bobo, Wang Quan, Wei Mingtian, Yue Yumin, Li Xiaojun
Department of General Surgery, Shaanxi Provincial People's Hospital, Xi'an, China.
Ambulatory Surgery Center of Xijing Hospital, Fourth Military Medical University, Xi'an, China.
Front Oncol. 2023 Feb 15;13:1116502. doi: 10.3389/fonc.2023.1116502. eCollection 2023.
There is controversy about the outcomes of prophylactic ileostomy the specimen extraction site (SES) after laparoscopic rectal cancer surgery (LRCS). We, therefore, performed a meta-analysis to determine the efficacy and safety of stoma through the SES versus new site (NS).
All relevant studies from 1997 to 2022 were searched in the PubMed, EMBASE, Cochrane Library, CNKI, VIP databases. This meta-analysis was performed using RevMan software 5.3 for statistical analysis.
7 studies with 1736 patients were included. The present meta-analysis noted that prophylactic ileostomy SES was associated with a higher risk of overall stoma-related complications, especially parastomal hernia (OR, 2.39, 95% CI 1.43-4.00; p=0.0008). No statistical difference was found in terms of wound infection, ileus, stoma edema, stoma prolapse, stoma necrosis, stoma infection, stoma bleeding, stoma stenosis, skin inflammation around the stoma, stoma retraction and postoperative pain score on postoperative day 1 and 3 between SES group and NS group. However, prophylactic ileostomy SES was associated with lesser blood loss (MD = -0.38, 95% CI: -0.62 - -0.13; p=0.003), shorter operation time(MD = -0.43, 95% CI: -0.54 - -0.32 min; p<0.00001), shorter post-operative hospital stay (MD = -0.26, 95% CI: -0.43 - -0.08; p=0.004), shorter time to first flatus(MD = -0.23, 95% CI: -0.39 - -0.08; p=0.003) and lower postoperative pain score on postoperative day 2.
Prophylactic ileostomy SES after LRCS reduces new incision, decreases operative time, promotes postoperative recovery, and improves cosmetic outcomes, but may increase the incidence of parastomal hernias. The vast majority of parastomal hernias can be repaired by closing the ileostomy, therefore SES remain an option for temporary ileostomy after LRCS.
关于腹腔镜直肠癌手术(LRCS)后预防性回肠造口术在标本取出部位(SES)的效果存在争议。因此,我们进行了一项荟萃分析,以确定通过SES造口与新部位(NS)造口的有效性和安全性。
在PubMed、EMBASE、Cochrane图书馆、CNKI、VIP数据库中检索1997年至2022年的所有相关研究。使用RevMan软件5.3进行这项荟萃分析以进行统计分析。
纳入了7项研究,共1736例患者。本荟萃分析指出,在SES进行预防性回肠造口术与总体造口相关并发症的较高风险相关,尤其是造口旁疝(OR,2.39,95%CI 1.43 - 4.00;p = 0.0008)。SES组和NS组在伤口感染、肠梗阻、造口水肿、造口脱垂、造口坏死、造口感染、造口出血、造口狭窄、造口周围皮肤炎症、造口回缩以及术后第1天和第3天的术后疼痛评分方面未发现统计学差异。然而,在SES进行预防性回肠造口术与失血量较少(MD = -0.38,95%CI:-0.62 - -0.13;p = 0.003)、手术时间较短(MD = -0.43,95%CI:-0.54 - -0.32分钟;p < 0.00001)、术后住院时间较短(MD = -0.26,95%CI:-0.43 - -0.08;p = 0.004)、首次排气时间较短(MD = -0.23,95%CI:-0.39 - -0.08;p = 0.003)以及术后第2天的术后疼痛评分较低相关。
LRCS后在SES进行预防性回肠造口术可减少新切口、缩短手术时间、促进术后恢复并改善美容效果,但可能增加造口旁疝的发生率。绝大多数造口旁疝可通过关闭回肠造口进行修复,因此SES仍然是LRCS后临时回肠造口术的一种选择。